Fuso Pharmaceutical Industries,Ltd.
Fuso Pharmaceutical Industries,Ltd.
Share · JP3823600006 (XTKS)
Overview
No Price
Closing Price XTKS 29.10.2025: 2.114,00 JPY
29.10.2025 05:43
Current Prices from Fuso Pharmaceutical Industries,Ltd.
ExchangeTickerCurrencyLast TradePriceDaily Change
XTKS: Tokyo
Tokyo
4538.T
JPY
29.10.2025 05:43
2.114,00 JPY
-35,00 JPY
-1,63 %
Share Float & Liquidity
Free Float 59,58 %
Shares Float 5,09 M
Shares Outstanding 8,54 M
Company Profile for Fuso Pharmaceutical Industries,Ltd. Share
Fuso Pharmaceutical Industries,Ltd. manufactures and sells pharmaceutical products in Japan. The company offers ethical drugs, such as injectables and artificial kidney dialysates; and medical machinery and equipment. It also rents real estate properties. The company was founded in 1937 and is headquartered in Osaka, Japan.
Get up to date insights from finAgent about Fuso Pharmaceutical Industries,Ltd.

Company Data

Name Fuso Pharmaceutical Industries,Ltd.
Company Fuso Pharmaceutical Industries,Ltd.
Website https://www.fuso-pharm.co.jp
Primary Exchange XTKS Tokyo
ISIN JP3823600006
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Mikio Toda
Market Capitalization 19 Mrd.
Country Japan
Currency JPY
Employees 1,4 T
Address 1-7-10, Doshomachi, 541-0045 Osaka
IPO Date 2001-01-01
Dividends from 'Fuso Pharmaceutical Industries,Ltd.'
Ex-Date Dividend per Share
29.09.2025 45,00 JPY

Ticker Symbols

Name Symbol
Tokyo 4538.T
More Shares
Investors who hold Fuso Pharmaceutical Industries,Ltd. also have the following shares in their portfolio:
PERU 20/31
PERU 20/31 Bond
ZOETIS 18/21
ZOETIS 18/21 Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025